Related Experiment Videos

Interaction of duramycin with artificial and natural membranes

Biochemistry
|August 13, 1985
PubMed

Insights

Duramycin, an antibiotic, aggregates lipid vesicles and inhibits calcium uptake by interacting with phosphatidylethanolamine. Resistance emerged when this lipid was absent, confirming duramycin

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Microbiology

Background:

  • Duramycin is a polypeptide antibiotic derived from Streptomyces cinnamomeus.
  • Its mechanism of action on biological membranes is not fully understood.

Purpose of the Study:

  • To investigate the molecular interactions of duramycin with lipid membranes.
  • To elucidate the role of specific lipids in duramycin's biological activity.

Main Methods:

  • Lipid vesicle aggregation assays.
  • Measurement of ATP-dependent Ca2+ uptake in sarcoplasmic reticulum vesicles.
  • Reconstitution of bacteriorhodopsin proton pump.
  • Isolation and characterization of a duramycin-resistant bacterial strain.

Main Results:

  • Duramycin induced aggregation of vesicles containing unsaturated phosphatidylethanolamine (PE) and monogalactosyl diglyceride (MGDG).
  • It inhibited Ca2+ uptake in sarcoplasmic reticulum vesicles without affecting ATP hydrolysis.
  • Duramycin selectively inhibited the bacteriorhodopsin proton pump in PE-containing vesicles.
  • A duramycin-resistant Bacillus subtilis strain lacked PE and showed resistance to duramycin's effects.

Conclusions:

  • Duramycin's activity is dependent on the presence of specific membrane lipids, particularly phosphatidylethanolamine.
  • The antibiotic likely recognizes a specific membrane conformation induced by PE or MGDG.
  • Lipid composition is crucial for cellular susceptibility to duramycin.

Related Concept Videos